Skip to Content
You are currently on the new version of our website. Access the old version .
VaccinesVaccines
  • Brief Report
  • Open Access

13 November 2022

10 Pages

Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina

,
,
,
,
,
,
,
,
…
1
The Biostatistics Center, George Washington University, Rockville, MD 20852, USA
2
Division of Pediatric Endocrinology, Department of Pediatrics, WakeMed Health and Hospitals, Raleigh, NC 27610, USA
3
Department of Tropical Medicine, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70118, USA
4
Department of Family Medicine, Atrium Health Carolinas Medical Center, Charlotte, NC 28262, USA
This article belongs to the Special Issue Epidemiology, Vaccination and Public Health

Abstract

We characterize the overall incidence and risk factors for breakthrough infection among fully vaccinated participants in the North Carolina COVID-19 Community Research Partnership cohort. Among 15,808 eligible participants, 638 reported a positive SARS-CoV-2 test after vaccination. Factors associated with a lower risk of breakthrough in the time-to-event analysis included older age, prior SARS-CovV-2 infection, higher rates of face mask use, and receipt of a booster vaccination. Higher rates of breakthrough were reported by participants vaccinated with BNT162b2 or Ad26.COV2.S compared to mRNA-1273, in suburban or rural counties compared to urban counties, and during circulation of the Delta and Omicron variants.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.